v3.26.1
Cash, Cash Equivalents, Restricted Cash, and Marketable Securities
6 Months Ended
Jun. 30, 2026
Cash and Cash Equivalents [Abstract]  
Cash, Cash Equivalents, Restricted Cash, and Marketable Securities
6.
Cash, Cash Equivalents, Restricted Cash, and Marketable Securities

 

The following tables summarize the Company’s marketable securities held as of June 30, 2026 and December 31, 2025.

 

 

 

June 30, 2026

 

 

 

Amortized Cost

 

 

Gross Unrealized Gains

 

 

Gross Unrealized Losses

 

 

Fair Value

 

Marketable securities

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury bills and U.S. Treasury notes

 

 

351,589

 

 

 

 

 

 

(551

)

 

 

351,038

 

 

$

351,589

 

 

$

 

 

$

(551

)

 

$

351,038

 

 

 

 

December 31, 2025

 

 

Amortized Cost

 

 

Gross Unrealized Gains

 

 

Gross Unrealized Losses

 

 

Fair Value

 

Marketable securities

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury bills and U.S. Treasury notes

 

 

174,776

 

 

 

93

 

 

 

 

 

 

174,869

 

 

$

174,776

 

 

$

93

 

 

$

 

 

$

174,869

 

 

The Company determined that there was no material credit risk associated with the above investments as of June 30, 2026 and December 31, 2025. The Company has the intent and ability to hold these securities until recovery. As a result, the Company did not record any charges for credit-related impairments for its marketable securities during the six months ended June 30, 2026 and 2025. No available-for-sale debt securities held as of June 30, 2026 had remaining maturities greater than 21 months.